ProQuest Associates IV LLC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 65 filers reported holding IMMUNE DESIGN CORP in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ProQuest Associates IV LLC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q3 2018$4,266,000
-24.2%
1,236,3940.0%8.06%
-7.0%
Q2 2018$5,626,000
+37.9%
1,236,3940.0%8.66%
+84.6%
Q1 2018$4,080,000
-15.4%
1,236,3940.0%4.69%
-26.8%
Q4 2017$4,822,000
-67.0%
1,236,394
-12.5%
6.40%
-56.3%
Q3 2017$14,627,000
-23.6%
1,413,280
-28.0%
14.65%
-40.1%
Q2 2017$19,137,000
+43.4%
1,962,7200.0%24.47%
+509.5%
Q1 2017$13,346,000
+23.6%
1,962,7200.0%4.01%
+31.3%
Q4 2016$10,795,000
-27.4%
1,962,7200.0%3.06%
-25.4%
Q3 2016$14,877,000
-7.1%
1,962,7200.0%4.10%
-37.1%
Q2 2016$16,016,000
-37.2%
1,962,7200.0%6.52%
-34.3%
Q1 2016$25,515,000
-35.3%
1,962,7200.0%9.91%
+30.3%
Q4 2015$39,411,000
+64.6%
1,962,7200.0%7.61%
+34.2%
Q3 2015$23,945,000
-41.6%
1,962,720
-1.1%
5.67%
-32.6%
Q2 2015$40,967,000
-19.6%
1,983,858
-17.8%
8.41%
-49.4%
Q1 2015$50,960,000
-38.6%
2,414,040
-10.5%
16.62%
-60.5%
Q4 2014$82,975,0002,695,75742.05%
Other shareholders
IMMUNE DESIGN CORP shareholders Q4 2018
NameSharesValueWeighting ↓
Versant Venture Management, LLC 2,208,210$16,738,232,00018.66%
ProQuest Associates IV LLC 1,962,720$14,877,0004.10%
BVF INC/IL 1,200,000$9,096,0001.71%
Abingworth LLP 197,300$1,494,0001.43%
NEXTHERA CAPITAL LP 305,000$2,312,0001.42%
Cormorant Asset Management, LP 432,990$3,282,0000.36%
SPHERA FUNDS MANAGEMENT LTD. 203,000$1,539,0000.25%
DAFNA Capital Management LLC 40,000$303,0000.21%
Monashee Investment Management LLC 50,000$379,0000.13%
Eventide Asset Management 180,000$1,364,0000.08%
View complete list of IMMUNE DESIGN CORP shareholders